Pharma sector stocks today, June 19: IPCA Labs up 2.54%, Aurobindo Pharma gains 0.93%, Orchid Pharma falls 1.97%

Pharma stocks traded largely in positive territory on June 19, 2026, during the early morning session, with most stocks posting modest gains even as the broader market fell sharply. The Nifty 50 was down 0.82% at 23,970.40 and the S&P BSE Sensex fell 0.97% to 76,656.77. The S&P BSE Healthcare index gained 0.21% to 47,583.61 as of around 9:38–9:39 AM, significantly outperforming the broader market and reflecting defensive buying in the pharma space.

Top Gainers

• IPCA Labs was the top gainer, rising 2.54% on BSE to ₹1,583.45 and 2.81% on NSE to ₹1,586.90.
• Aurobindo Pharma gained 0.93% on BSE to ₹1,456.40 and 0.92% on NSE to ₹1,457.00.
• Natco Pharma rose 0.83% on BSE to ₹890.55 and 0.86% on NSE to ₹891.10.
• Sudeep Pharma gained 0.83% on BSE to ₹856.85 and 0.83% on NSE to ₹859.60.
• Aarti Drugs rose 0.70% on BSE to ₹372.85 and 0.47% on NSE to ₹371.90.
• Strides Pharma Science gained 0.59% on BSE to ₹1,117.70 and 0.96% on NSE to ₹1,121.50.
• Sun Pharma rose 0.47% on BSE to ₹1,832.50 and 0.45% on NSE to ₹1,833.00.
• Wockhardt gained 0.44% on BSE to ₹1,998.00 and 0.40% on NSE to ₹1,997.10.
• Panacea Biotech rose 0.39% on BSE to ₹536.45 and 0.14% on NSE to ₹535.60.
• Zydus Lifesciences gained 0.26% on BSE to ₹1,077.10 and 0.18% on NSE to ₹1,076.30.
• Glenmark Pharma rose 0.13% on BSE to ₹2,157.05 and 0.25% on NSE to ₹2,159.40.
• Mankind Pharma edged up 0.04% on BSE to ₹2,406.00 and 0.11% on NSE to ₹2,408.70.
• Ajanta Pharma rose 0.10% on BSE to ₹3,077.95 and 0.16% on NSE to ₹3,078.60.
• Cipla was broadly flat, up just 0.02% on BSE to ₹1,356.10 and unchanged at 0.00% on NSE to ₹1,355.50.
• Torrent Pharma was nearly unchanged, up 0.01% on BSE to ₹4,443.35 while slipping 0.01% on NSE to ₹4,445.00.
• Dr. Reddy’s Lab was nearly flat, down 0.27% on BSE to ₹1,264.35 while gaining 0.09% on NSE to ₹1,268.70.

Major Losers

• Orchid Pharma was the top loser, falling 1.97% on BSE to ₹990.00 and 2.06% on NSE to ₹987.45.
• Alembic Pharma declined 0.50% on BSE to ₹746.00 and 0.49% on NSE to ₹746.00.
• Indoco Remedies dropped 0.50% on BSE to ₹230.75 and 0.54% on NSE to ₹230.83.
• Divis Laboratories fell 0.18% on BSE to ₹6,755.15 and 0.19% on NSE to ₹6,754.00.
• J.B. Chemicals declined 0.08% on BSE to ₹2,197.05 and 0.29% on NSE to ₹2,192.10.
• Lupin was nearly flat, down 0.05% on BSE to ₹2,326.45 while gaining 0.07% on NSE to ₹2,328.70.
• Biocon dropped 0.12% on BSE to ₹413.15 and 0.13% on NSE to ₹413.30.

Pharma stocks showed a broadly positive trend on June 19, with the S&P BSE Healthcare index gaining 0.21% even as the broader Sensex fell nearly 1%. This defensive outperformance highlights the sector’s role as a safe haven during broader market weakness. IPCA Labs was the standout performer with a 2.54% gain. Losses were limited and mild, with only Orchid Pharma posting a decline of more than 1%.

*Disclaimer: Investments in equities and securities are subject to market risks. The information provided in this article is for informational and educational purposes only and should not be construed as investment advice, stock recommendations, or financial guidance. Investors should conduct their own research and consult qualified financial advisors before making any investment decisions. Past performance is not indicative of future results. Market conditions can change rapidly, and there is no guarantee of future returns. Always assess your risk tolerance, financial goals, and investment horizon before investing in any security or financial product.*